Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU Topicsrenal-metabolic

ICU · renal-metabolic

Acute Severe Rhabdomyolysis — Comprehensive ICU Management

Also known as Rhabdomyolysis · Rhabdo · Myoglobinuria · Crush syndrome · Muscle breakdown · Creatine kinase elevation · Myoglobin nephrotoxicity · Exertional rhabdomyolysis · Statin-induced rhabdomyolysis

Rhabdomyolysis — skeletal muscle breakdown releasing intracellular contents (myoglobin, creatine kinase, potassium, phosphate, urate) into the circulation → AKI (myoglobin nephrotoxicity + intratubular cast formation + volume depletion), hyperkalaemia (lethal arrhythmia), hypocalcaemia, metabolic acidosis, compartment syndrome. Causes: crush injury (trauma, building collapse, prolonged immobilisation), exertional (marathon, seizures, agitation/delirium), drugs (statins 1 — especially with fibrates/calcineurin inhibitors, illicit drugs — MDMA, cocaine, heroin), infections (influenza, legionella, coxsackie, severe sepsis), metabolic (hypokalaemia, hypophosphataemia, DKA/HHS), genetic (McArdle disease, CPT deficiency, malignant hyperthermia), inflammatory (polymyositis, dermatomyositis). Diagnosis: CK 5x ULN (1000 IU/L — typically 10,000-100,000+) + myoglobinuria (dark/tea-coloured urine + positive blood on dipstick but NO RBCs on microscopy) + hyperkalaemia + elevated AST/ALT (muscle-derived). Management: AGGRESSIVE IV FLUIDS (the 1 intervention — high urine flow — about 400 mL/h crystalloid, up to 12 L or more per day in severe crush — crystalloid, ideally balanced solution), treat hyperkalaemia (calcium gluconate + insulin/dextrose), urine alkalinisation (controversial — sodium bicarbonate mainly in acidotic patients — evidence is limited), renal replacement therapy if severe AKI (CRRT preferred), fasciotomy if compartment syndrome. Mortality: about 10 per cent overall, higher when AKI develops.

high20 referencesUpdated 26 July 202612 min readSource-verified · Sept 2026

Checked against its sources on 2 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • CK ≥5000 IU/L (severe rhabdomyolysis) + dark urine + hyperkalaemia = RHABDOMYOLYSIS with high AKI risk — start AGGRESSIVE high-volume IV crystalloid immediately (about 400 mL/h, scaled up to 12 L or more per day in severe crush)
  • Hyperkalaemia (K ≥5.5 mmol/L, seen in 13% of severe cases) can be SEVERE and REFRACTORY — potassium is continuously released from necrotic muscle — IV calcium for ECG changes or K ≥6.5, insulin–dextrose shifts K intracellularly, nebulised salbutamol 10–20 mg adds ~1.2 mmol/L of lowering — RRT if refractory
  • Compartment syndrome (pain on passive stretch + tense compartment + paraesthesia; pulselessness is LATE) = SURGICAL EMERGENCY — fasciotomy is the only effective treatment; decompress when the delta pressure (diastolic minus compartment pressure) falls under 30 mmHg
  • Hypocalcaemia is COMMON (41% of severe cases, Ca ≤2.00 mmol/L) and usually asymptomatic — management is judicious: calcium homeostasis is biphasic, with recovery-phase REBOUND hypercalcaemia recognised — reserve IV calcium for symptomatic hypocalcaemia or hyperkalaemic ECG changes
  • Statins + gemfibrozil + other interacting drugs = high-risk combination for rhabdomyolysis — monitor CK and stop at first sign of muscle pain
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • CK ≥5000 IU/L (severe rhabdomyolysis) + dark urine + hyperkalaemia = RHABDOMYOLYSIS with high AKI risk — start AGGRESSIVE high-volume IV crystalloid immediately (about 400 mL/h, scaled up to 12 L or more per day in severe crush)
  • Hyperkalaemia (K ≥5.5 mmol/L, seen in 13% of severe cases) can be SEVERE and REFRACTORY — potassium is continuously released from necrotic muscle — IV calcium for ECG changes or K ≥6.5, insulin–dextrose shifts K intracellularly, nebulised salbutamol 10–20 mg adds ~1.2 mmol/L of lowering — RRT if refractory
  • Compartment syndrome (pain on passive stretch + tense compartment + paraesthesia; pulselessness is LATE) = SURGICAL EMERGENCY — fasciotomy is the only effective treatment; decompress when the delta pressure (diastolic minus compartment pressure) falls under 30 mmHg
  • Hypocalcaemia is COMMON (41% of severe cases, Ca ≤2.00 mmol/L) and usually asymptomatic — management is judicious: calcium homeostasis is biphasic, with recovery-phase REBOUND hypercalcaemia recognised — reserve IV calcium for symptomatic hypocalcaemia or hyperkalaemic ECG changes
  • Statins + gemfibrozil + other interacting drugs = high-risk combination for rhabdomyolysis — monitor CK and stop at first sign of muscle pain
The one-line answer

Rhabdomyolysis is skeletal muscle breakdown spilling myoglobin, creatine kinase, potassium, phosphate and urate into the circulation — producing the quartet every CICM stem tests: AKI (acute renal failure affected half of one severe-case series and about 46 per cent of a 475-patient hospital cohort), hyperkalaemia (13 per cent of severe cases at 5.5 mmol/L or above), hypocalcaemia (41 per cent at 2.00 mmol/L or below) and metabolic acidosis. Diagnose it on CK above five times the upper limit of normal or above 1000 IU/L — values may reach 100,000 IU/L — with pigmenturia; urine myoglobin is positive in only about a fifth of cases, so a negative result never excludes it. The number-one intervention is early high-volume IV crystalloid — about 400 mL/h, scaled up to 12 L or more per day of alkaline solution in severe crush; treat the hyperkalaemia (IV calcium for ECG changes or K at or above 6.5, insulin with glucose, nebulised salbutamol, dialysis if refractory), manage the hypocalcaemia judiciously — calcium is biphasic, with rebound hypercalcaemia described in recovery — and decompress compartment syndrome when the delta pressure falls under 30 mmHg.[3][4][1][2][7][6][10][11][20]

Meet the patient

A 28-year-old man is extricated after eight hours under a collapsed wall, both lower limbs and his pelvis crushed. He arrives bradycardic at 46, blood pressure 78/50, GCS 14. The ECG shows a wide QRS with peaked T waves merging towards a sine wave. The venous gas reads K 8.2 mmol/L, pH 7.08, lactate 9, and the catheter drains dark tea-coloured urine — the severe end of the published spectrum, in which hyperkalaemia, hypocalcaemia, acute renal failure and pigmenturia cluster together.[3][2]

The question that decides whether he lives the next ten minutes is the question that decides every rhabdomyolysis: is the potassium still being released from dying muscle? Because if it is, no single insulin-dextrose bolus will hold it. Hold that thought, and the fluid-first, calcium-paradox, fasciotomy-clock logic below falls into place.[8][9]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References20ShowHide
  1. [1]Stahl K, Rastelli E, Schoser B, et al. A systematic review on the definition of rhabdomyolysis. J Neurol, 2020.PMID 30617905
  2. [2]Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M Rhabdomyolysis: review of the literature. Neuromuscul Disord, 2014.PMID 24946698
  3. [3]Veenstra J, Smit WM, Krediet RT, Arisz L Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant, 1994.PMID 7970089
  4. [4]Melli G, Chaudhry V, Cornblath DR Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore), 2005.PMID 16267412
  5. [5]Mikkelsen TS, Toft P Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand, 2005.PMID 15954972
  6. [6]Better OS Early fluid resuscitation in patients with rhabdomyolysis. Nat Rev Nephrol, 2011.PMID 21587227
  7. [7]Cho YS, Lim H, Kim SH Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication. Emerg Med J, 2007.PMID 17384382
  8. [8]Batterink J, Cessford TA, Taylor RA, et al. Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev, 2015.PMID 35658162
  9. [9]Harel Z, Kamel KS. Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review. PLoS One, 2016.PMID 27148740
  10. [10]Geldermann N, et al. Acute hyperkalaemia in emergency care: evidence-based approaches. Emerg Med J, 2026.PMID 41506858
  11. [11]McQueen MM, Court-Brown CM. Compartment monitoring in tibial fractures. The pressure threshold for decompression. J Bone Joint Surg Br, 1996.PMID 8898137
  12. [12]Schmidt AH Acute Compartment Syndrome. Orthop Clin North Am, 2016.PMID 27241376
  13. [13]Richards JR, Wang CG, Fontenette RW, et al. Rhabdomyolysis, Methamphetamine, Amphetamine and MDMA Use: Associated Factors and Risks. J Dual Diagn, 2020.PMID 32644906
  14. [14]Thompson PD, Clarkson P, Karas RH Statin-associated myopathy. JAMA, 2003.PMID 12672737
  15. [15]Wu J, Song Y, Li H, Chen Y Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur J Clin Pharmacol, 2009.PMID 19756555
  16. [16]Link E, Parish S, Armitage J, et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med, 2008.PMID 18650507
  17. [17]Warren JD, Blumbergs PC, Thompson PD Rhabdomyolysis: a review. Muscle Nerve, 2002.PMID 11870710
  18. [18]Torres PA, Helmstetter JA, Kaye AM, Kaye AD Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J, 2015.PMID 25829882
  19. [19]Yamaji F, et al. Rhabdomyolysis: What you need to know. J Trauma Acute Care Surg, 2026.PMID 42479694
  20. [20]Das A, et al. Rhabdomyolysis-Induced Resistant Hypercalcemia During the Recovery Phase of Acute Kidney Injury. Cureus, 2026.PMID 42306390

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute severe hyperkalaemia: emergency management algorithmRenal/MetabolicNextDrug-induced kidney injury and acute interstitial nephritisRenal/Metabolic